Cytimmune

We are using nanotechnology to make novel combination therapies that can attack solid tumors in ways that were previously not possible.

[Cytimmune @CytImmune]

Researchers from Cytimmune Sciences presented new data at a cancer therapeutics conference in Boston, MA demonstrating the potential of their nanoparticle-based platform to supercharge synergistic immune system stimulators called cytokines. https://t.co/xue1IMEwYe

[METUPUK @METUPUKorg]

Please fill in this survey-

[National Cancer Institute @theNCI]

NCI's Community Oncology Research Program brings #clinicaltrials to people in the communities where they live: https://t.co/2oSrcW8gTL

[Cytimmune @CytImmune]

@Majormac1 @theNCI @LtColMac1 In defense of the NCI, when nobody else would take a chance on our approach to treating cancer, the NCI stepped up. For many unproven technologies they are a lifeline. We hope to help the 41k (and more), and the NCI has given us a chance.

[theresa's research @MetastaticOdds]

We are excited to be @MetastasisRS meeting @Princeton & are looking forward to hearing the young investigators research #metastatic #breastcancer

[METAvivor @metavivor]

100% of donations to METAvivor go towards MBC research. Make a difference by making a donation today: https://t.co/UcM70K5ddk #ThisIsMBC #ad

[Cytimmune @CytImmune]

@athleteonchemo @ehgsmith @abcdiagnosis So sorry to hear about the denial and progression. I can only imagine your frustration.

[Julie Fleshman @JulieFleshman]

Still a lot of ways you can get involved even though Advocacy Day is over! We can’t do it without you – learn how to continue to #DemandBetter w/@PanCAN https://t.co/sP8GM5KgJy #PANCaware

[Jeff Galvin @jeffreygalvin]

A great turnout at the #SAPA-DC conference today. Happy to be speaking with members of the #Maryland #research community and working together to cure more diseases with #gene and cell therapies. @NIH @NIDCR @NIBIBgov @Advaxis @theNCI @davidoarr @CytImmune #immunotherapy #cancer

[Shaalan Beg MD MBA FASCO @ShaalanBeg]

This is why I think the phrase #chemobrain is deceptive. It oversimplifies, and belittles, a complex interaction between cancer, cancer treatments and the brain.
Go ahead, spend the next hour (or 2) studying this infographic and see what you think. https://t.co/PikW3oddp8

[Cytimmune @CytImmune]

@CancerCouch @mskcc Congrats. Love to read more, but getting a 404 error on the link. : /

[LAB - Life & Breath @LABLifeBreath]

One week until Life & Breath Rally on the east lawn in front of the Capitol Building in Washington DC!
https://t.co/htXuWIgrLI
#LungCancer #433aDay #lcsm

[Cytimmune @CytImmune]

@notSoJunkDNA Fixed on behalf of those of us who can't be there this year.

[METUP @METUPorg]

It’s great to hear @NCIDirector really cares about us at conferences like #AARC18 , but @CultPerfectMoms @owlchick_april & the over 41,000 will continue to die of #metastasticBC until this happens. #bcsm https://t.co/YJsEltHJt4

[METUP @METUPorg]

Multisite study enrolling for TNBC or HR+/HER2-. Must have either a PIK3CA, AKT1 or PTEN mutation. No prior chemo, no brain mets, no prior AKT inhibitor. Does allow men.
AKT Inhibitor May Overcome Chemotherapy Resistance in 2 Breast Cancer Subtypes via @onclive

[Chris Frew @BiotechMd]

Impressive panel for the 1st @ISPE_CBA Women In Pharma event at @montgomerycoll - @REGENXBIO @DrJudyStaveley @immunomix @AstraZeneca

[Dr. Kelly Shanahan @stage4kelly]

Thank you @medivizor for sharing my story. I'm #NotDeadYet and hope to keep advocating for #ResearchNotRibbons for #metastaticbreastcancer https://t.co/7tZwuTqYrw

[The Underbelly @TheUnder_Belly]

All of these women and their families were profoundly impacted by Metastatic Breast Cancer. They have all died because there is no single or combination of medications that can stop the disease once the cancer has gone #BeyondTheBreast

[Eric Topol @EricTopol]

When the number of trials exceeds the number of eligible, participating patients https://t.co/qOewGQbDNs
the 1100 PD-1, PD-L1 #cancer trials from @jocelynkaiser's "Too Much of A Good Thing" @sciencemagazine